Concepedia

Martina Gruber

MG

Statistics

Publications

6

Citations

165

H-Index

6

Active since

2008

Affiliations

Universität Innsbruck(Current)

Innsbruck Medical University

KU Leuven

Martina Gruber is an author at Universität Innsbruck specializing in pharmacotherapy, tumor microenvironment, and financial risk management.

Top concepts

Publications per year

2008–2021

6

Publications

6

The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models

Florian Handle, Martin Puhr, Georg Schaefer et al. · Molecular Cancer Therapeutics · 2018 · 43 citations · Full text

The stem cell inhibitor salinomycin decreases colony formation potential and tumor‐initiating population in docetaxel‐sensitive and docetaxel‐resistant prostate cancer cells

Martina Gruber, Florian Handle, Zoran Čulig · The Prostate · 2019 · 32 citations · Full text

Bactericidal and Fungicidal Activity of <i>N</i> -Chlorotaurine Is Enhanced in Cystic Fibrosis Sputum Medium

Martina Gruber, Ivan Moser, Markus Nagl et al. · Antimicrobial Agents and Chemotherapy · 2017 · 30 citations · Full text

p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer

Martina Gruber, Lavinia Ferrone, Martin Puhr et al. · Endocrine Related Cancer · 2020 · 28 citations · Full text

, , +12

MYC-Mediated Ribosomal Gene Expression Sensitizes Enzalutamide-resistant Prostate Cancer Cells to EP300/CREBBP Inhibitors

Tobias Furlan, Alexander Kirchmair, Natalie Sampson et al. · American Journal Of Pathology · 2021 · 22 citations · Full text

1–5 of 6